Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects dopaminergic neurons in the substantia nigra. It is characterized by motor symptoms such as tremors, rigidity, and bradykinesia, as well as non-motor symptoms including cognitive impairment and mood disorders. This article aims to provide a comprehensive overview of PD for healthcare professionals.
The exact cause of PD remains unknown, but it is thought to involve a combination of genetic and environmental factors. Pathologically, PD is characterized by the loss of dopamine-producing neurons in the substantia nigra and the presence of Lewy bodies, which are protein aggregates primarily composed of alpha-synuclein. This leads to an imbalance in the basal ganglia circuitry, resulting in the characteristic motor symptoms of PD.
The cardinal motor symptoms of PD include resting tremor, rigidity, bradykinesia, and postural instability. Non-motor symptoms such as autonomic dysfunction, cognitive impairment, mood disorders, and sleep disturbances are also common and often precede the onset of motor symptoms. The disease progression is typically asymmetric, with symptoms appearing on one side of the body before the other.
PD is primarily diagnosed based on clinical criteria, with neuroimaging used to rule out other causes of parkinsonism. The management of PD involves a multidisciplinary approach, with pharmacological treatment aimed at managing symptoms and improving quality of life. Levodopa remains the most effective medication for motor symptoms, while non-pharmacological interventions include physical and occupational therapy.
Understanding PD's complexities is crucial for healthcare professionals to provide optimal care. Although there is currently no cure, advances in research continue to shed light on the disease's pathophysiology, potentially paving the way for more effective treatments in the future.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation